{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:25:06Z","timestamp":1762521906327,"version":"3.37.3"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Seppo Nieminen Testament Fund"},{"name":"Finnish Cancer Society"},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","award":["132385"],"award-info":[{"award-number":["132385"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Suomen Akatemia","doi-asserted-by":"publisher","award":["260 931"],"award-info":[{"award-number":["260 931"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Competitive State Research Financing of Tampere University Hospital","award":["9P053"],"award-info":[{"award-number":["9P053"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153413","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T17:42:26Z","timestamp":1461260546000},"page":"e0153413","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial"],"prefix":"10.1371","volume":"11","author":[{"given":"Thea","family":"Veitonm\u00e4ki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu J.","family":"Murtola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsi","family":"Talala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimmo","family":"Taari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teuvo","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"SP Hussain","year":"2007","journal-title":"Int J Cancer"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"SI Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.freeradbiomed.2012.02.035","article-title":"Emerging avenues linking inflammation and cancer","volume":"52","author":"JK Kundu","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"7203","key":"ref4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"A Mantovani","year":"2008","journal-title":"Nature"},{"issue":"1","key":"ref5","first-page":"198","article-title":"Cyclooxygenase-2 expression in human esophageal carcinoma","volume":"59","author":"KC Zimmermann","year":"1999","journal-title":"Cancer Res"},{"issue":"7","key":"ref6","first-page":"1276","article-title":"Expression of cyclooxygenase-2 in human gastric carcinoma","volume":"57","author":"A Ristim\u00e4ki","year":"1997","journal-title":"Cancer Res"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N","article-title":"Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors","volume":"91","author":"A Kokawa","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"CE Eberhart","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"S Gupta","year":"2000","journal-title":"Prostate"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2013.09.001","article-title":"Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science","volume":"345","author":"IH Sahin","year":"2014","journal-title":"Cancer Lett"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"AM Algra","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwq437","article-title":"Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis 11","volume":"173","author":"SE Daugherty","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"C Bosetti","year":"2012","journal-title":"Ann Oncol"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"e114633","DOI":"10.1371\/journal.pone.0114633","article-title":"Non- Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study","volume":"9","author":"FM Shebl","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/bjc.2014.473","article-title":"Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer","volume":"111","author":"TV Macfarlane","year":"2014","journal-title":"Br J Cancer"},{"issue":"9959","key":"ref16","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"ERSPC Investigators. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"FH Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djt038","article-title":"Prostate cancer mortality in the Finnish randomized screening trial","volume":"105","author":"TP Kilpel\u00e4inen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"ref18","unstructured":"Statistics Finland. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.stat.fi\" xlink:type=\"simple\">http:\/\/www.stat.fi<\/ext-link>"},{"issue":"Suppl 2","key":"ref19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1465-5101.2003.04402.x","article-title":"Determining the cause of death in randomized screening trial(s) for prostate cancer","volume":"92","author":"HJ De Koning","year":"2003","journal-title":"BJU Int"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.23126","article-title":"Assessment of causes of death in a prostate cancer screening trial","volume":"122","author":"T M\u00e4kinen","year":"2008","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0379-0738(00)00300-5","article-title":"The validity of death certificates: routine validation of death certification and its effects on mortality statistics","volume":"115","author":"RA Lahti","year":"2001","journal-title":"Forensic Sci Int"},{"issue":"2\u20133","key":"ref22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0379-0738(02)00418-8","article-title":"Cause-of-death query in validation of death certification by expert panel; effects on mortality statistics in Finland, 1995","volume":"131","author":"RA Lahti","year":"2003","journal-title":"Forensic Sci Int"},{"year":"2002","author":"J Martikainen","key":"ref23"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","article-title":"Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis","volume":"3","author":"A Gonz\u00e1lez-P\u00e9rez","year":"2003","journal-title":"BMC Cancer"},{"key":"ref25","unstructured":"World Health Organization. ATC\/DDD index database. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.whocc.no\/atc_ddd_index\/\" xlink:type=\"simple\">http:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link> accessed 1.7.2011"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"H Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"9826","key":"ref27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"PM Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"9573","key":"ref28","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"E Flossmann","year":"2007","journal-title":"Lancet"},{"issue":"5B","key":"ref29","first-page":"3177","article-title":"Aspirin use and mortality from cancer in a prospective cohort study","volume":"24","author":"LD Ratnasinghe","year":"2004","journal-title":"Anticancer Res"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jnci\/djh084","article-title":"Aspirin use and pancreatic cancer mortality in a large United States cohort","volume":"96","author":"EJ Jacobs","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"ref31","first-page":"1564","article-title":"Use of Aspirin postdiagnosis improves survival for colon cancer patients Br J Cancer","volume":"106","author":"E Bastiaannet","year":"2012"},{"issue":"9","key":"ref32","first-page":"1602","article-title":"Br J Cancer","volume":"107","author":"AJ Walker","year":"2012","journal-title":"Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/JTO.0b013e3182641bdc","article-title":"Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study","volume":"7","author":"TM Brasky","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.seminoncol.2014.04.006","article-title":"Platelets effects on tumor growth","volume":"41","author":"HA Goubran","year":"2014","journal-title":"Semin Oncol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"E. Gurpinar","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"9499","key":"ref36","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0140-6736(05)67725-2","article-title":"Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors","volume":"366","author":"G Danaei","year":"2005","journal-title":"Lancet"},{"key":"ref37","unstructured":"Finnish statistics on medicines 2007."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:34:49Z","timestamp":1588966489000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153413"}},"subtitle":[],"editor":[{"given":"Zoran","family":"Culig","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153413","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}